SALVATORI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 2.083
EU - Europa 960
AS - Asia 522
SA - Sud America 11
OC - Oceania 2
AF - Africa 1
Totale 3.579
Nazione #
US - Stati Uniti d'America 2.082
CN - Cina 393
IT - Italia 212
PL - Polonia 198
UA - Ucraina 168
DE - Germania 143
TR - Turchia 82
GB - Regno Unito 72
SE - Svezia 57
FI - Finlandia 39
FR - Francia 27
BE - Belgio 13
IR - Iran 13
BR - Brasile 9
RU - Federazione Russa 9
RO - Romania 8
NL - Olanda 7
SG - Singapore 6
IN - India 5
MY - Malesia 4
VN - Vietnam 4
ES - Italia 3
ID - Indonesia 3
IQ - Iraq 3
TW - Taiwan 3
AU - Australia 2
CH - Svizzera 2
KR - Corea 2
AR - Argentina 1
CA - Canada 1
CO - Colombia 1
GE - Georgia 1
IE - Irlanda 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
PK - Pakistan 1
TN - Tunisia 1
Totale 3.579
Città #
Woodbridge 290
Chandler 219
Jacksonville 204
Warsaw 198
Houston 162
Beijing 148
Ann Arbor 138
Fairfield 137
Ashburn 122
Wilmington 91
Nanjing 69
Ferrara 57
Izmir 53
Bologna 50
Seattle 49
Princeton 46
Addison 41
New York 41
Cambridge 40
Boardman 31
Shanghai 31
Bremen 28
Milan 28
Shenyang 20
Redwood City 18
Auburn Hills 16
Falls Church 14
Hebei 14
San Diego 14
Dearborn 13
Nanchang 13
Brussels 12
Jiaxing 12
Changsha 10
Los Angeles 10
Tianjin 10
San Jose 9
Mountain View 8
Guangzhou 7
Leiden 7
Hefei 6
Jinan 6
Lanzhou 6
Ningbo 6
Singapore 6
Zhengzhou 6
Cattolica 5
Des Moines 5
Cagliari 4
Dong Ket 4
Fuzhou 4
Indiana 4
Kunming 4
Leawood 4
Napoli 4
Norwalk 4
Orange 4
Padova 4
Ravenna 4
Hangzhou 3
Jakarta 3
Kundan 3
Pars 3
Taipei 3
Turin 3
Ankara 2
Ardabil 2
Campobasso 2
Castello Di Fiemme 2
Chengdu 2
Custom House 2
Edinburgh 2
Kansas City 2
Kilburn 2
Kirkuk 2
Kota Bharu 2
Kuala Lumpur 2
London 2
Modena 2
Rome 2
San Mateo 2
Southwark 2
Sydney 2
Anna 1
Augusta 1
Barcelona 1
Beirut 1
Bogotá 1
Bovisio Masciago 1
Buenos Aires 1
Carini 1
Carnago 1
Cartura 1
Changchun 1
Chiswick 1
Dublin 1
Easton 1
Eden Prairie 1
Foggia 1
Fort Worth 1
Totale 2.641
Nome #
Strategies for the adult haemoglobin (HbA) production in β0-thalassemia patients 166
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 162
SPR-based non-invasive prenatal testing for fetal sex determination 132
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 131
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 131
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 131
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 109
null 107
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 106
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 105
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 100
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients. 96
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 92
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 89
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 87
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 87
null 85
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 82
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 79
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 78
null 75
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 74
Gene therapy combined with HbF induction in beta-thalassemia 74
Development and molecular characterization of transgenic mice for beta-thalassemia 73
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 70
null 69
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 68
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 67
PNA-mediated alteration of mRNA splicing 65
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 64
Gene therapy and fetal hemoglobin induction 62
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 60
Cellular biosensors for the identification of fetal hemoglobin inducers 58
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 58
Readthrough of the premature stop codon beta039-thalassemia 57
Generation and molecular characterization of a transgenic mouse line carrying a mutated human °39 thalassemia -globin gene 57
Production of a cellular model for the screening of inducers of fetal haemoglobin 56
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 54
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 45
Control of Erwinia amylovora Growth by Moringa oleifera Leaf Extracts: In Vitro and in Planta Effects 45
null 40
UPF1 silenced cellular model systems for screening of read-through agents active on β039 thalassemia point mutation 37
PLCB3 Loss of Function Reduces Pseudomonas aeruginosa-Dependent IL-8 Release in Cystic Fibrosis 35
Effects of Moringa oleifera Leaf Extracts on Xanthomonas campestris pv. campestris 34
Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia 33
Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells 25
Evidences for miRNA regulation of BCL11A gene expression 17
Peptide nucleic acids targeting the murine beta-globin mRNAs selectively inhibit hemoglobin production in Murine Erythroleukemia (MEL) cells. 11
Tobramycin is a suppressor of premature termination codons. 10
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 10
Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance 6
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach 5
LINE-1 global DNA methylation, iron homeostasis genes, sex and age in sudden sensorineural hearing loss (SSNHL) 4
Totale 3.673
Categoria #
all - tutte 13.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 329
Totale 13.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019179 0 0 0 0 0 0 0 0 0 0 46 133
2019/2020629 124 17 21 70 31 70 46 53 42 102 34 19
2020/2021614 53 41 24 42 47 58 22 56 25 66 124 56
2021/2022469 45 39 13 15 29 23 22 18 15 44 39 167
2022/2023496 57 53 11 63 94 63 28 40 41 9 21 16
2023/2024301 22 40 19 7 32 64 56 25 5 18 13 0
Totale 3.673